[ad_1]
Jakarta, CNBC Indonesia – The good news comes from the Covid-19 vaccine from Sinovac Bontech Ltd, Coronavac. The vaccine is said to have proven its effectiveness in the final stages of trials in Brazil.
Quotation Reuters who launched Wall street journal On Tuesday (12/22/2020), the Butantan Institute in the state of Sao Paulo, which is conducting the final stage of the trial, reported the efficacy of the injection. In addition to Brazil, this vaccine is also being tested in Turkey and RI.
“The results of the Brazilian trial place CoronaVac above the 50% threshold that international scientists consider necessary to protect human beings,” according to the report.
“Butantan is ready on Wednesday (12/23/2020 local time) to announce CoronaVac’s level of effectiveness.”
However, Sinovac has yet to respond. In the middle of last week, the Brazilian Minister of Health said that the Sinovac vaccine could be ready for use in mid-February.
Meanwhile, several scientists hope that the efficacy of the vaccine will be comparable to other vaccines that have been announced to be 95% effective. At least the vaccines made by Pfizer / BioNTech and Moderna have shown it.
“Everyone expects an efficiency level of more than 90%,” said Domingos Alves, a professor at the Ribeirão Preto School of Medicine in São Paulo, who specializes in analyzing health data.
“The results of the first phase of the trial were excellent.”
Singapore announced that it will purchase this vaccine. The Philippines also plans to bring in 25 million doses by March.
(Head to head)
